Aldeyra Therapeutics (137.F) Q3 2024 Earnings

Aug 1Confirmed
Q4 2023
Q2 2024
Q3 2024
-0.26
-0.2
-0.14
-0.07

Details

Expected EPS
-0.191166283
Actual EPS
-0.25949
Surprise EPS
-0.07
Surprise Percent
-35.74%

Description

⁨Aldeyra Therapeutics⁩ (⁦137.F⁩) has reported earnings of ⁦-0.25949⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts